Patient-reported outcomes in moderate-to-severe plaque psoriasis with scalp involvement: results from a randomized, double-blind, placebo-controlled study of etanercept.

Tyring, S; Bagel, J; Lynde, C; Klekotka, P; Thompson, E H Z; Gandra, S R; Shi, Y; Kricorian, G

Tyring, S; Bagel, J; Lynde, C; Klekotka, P; Thompson, E H Z; Gandra, S R; Shi, Y; Kricorian, G.

J Eur Acad Dermatol Venereol ; 27(1): 125-8, 2013 Jan.

Article in En | MEDLINE | ID: mdl-22188302

Subject(s)

Immunoglobulin G/therapeutic use; Patient Satisfaction/statistics & numerical data; Psoriasis/drug therapy; Receptors, Tumor Necrosis Factor/therapeutic use; Scalp Dermatoses/drug therapy; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Etanercept; Female; Follow-Up Studies; Humans; Immunosuppressive Agents/therapeutic use; Injections, Subcutaneous; Male; Middle Aged; Psoriasis/complications; Psoriasis/diagnosis; Reference Values; Scalp Dermatoses/complications; Scalp Dermatoses/diagnosis; Self-Assessment; Severity of Illness Index; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Scalp Dermatoses / Immunoglobulin G / Patient Satisfaction / Receptors, Tumor Necrosis Factor Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2013 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google